TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nordic Bioscience A/S
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
324,920
|
236,409
|
313,570 |
| Earnings before taxes |
101,600
|
43,008
|
138,108 |
| Total assets |
425,370
|
291,155
|
271,867 |
| Current assets |
346,163
|
204,369
|
187,355 |
| Current liabilities |
273,455
|
186,470
|
155,053 |
| Equity capital |
111,251
|
61,597
|
71,667 |
| - share capital |
10,000
|
10,000
|
10,000 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
26.2%
|
21.2%
|
26.4% |
| Turnover per employee |
2,166
|
1,576
|
2,090 |
| Profit as a percentage of turnover |
31.3%
|
18.2%
|
44.0% |
| Return on assets (ROA) | |||
| Current ratio |
126.6%
|
109.6%
|
120.8% |
| Return on equity (ROE) |
91.3%
|
69.8%
|
192.7% |
| Change turnover |
88,511
|
-77,161
|
42,556 |
| Change turnover % |
37%
|
-25%
|
16% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.